Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
LRG1 destabilizes tumor vessels and restricts immunotherapeutic potency.
Med. 2021 Nov 12;2(11):1231-1252.e10. doi: 10.1016/j.medj.2021.10.002. Epub 2021 Nov 3.
Med. 2021.
PMID: 35590198
Free PMC article.
Angiopathic activity of LRG1 is induced by the IL-6/STAT3 pathway.
Dritsoula A, Dowsett L, Pilotti C, O'Connor MN, Moss SE, Greenwood J.
Dritsoula A, et al.
Sci Rep. 2022 Mar 22;12(1):4867. doi: 10.1038/s41598-022-08516-2.
Sci Rep. 2022.
PMID: 35318338
Free PMC article.
Item in Clipboard
Correction: LRG1 as a novel therapeutic target in eye disease.
De Rossi G, Da Vitoria Lobo ME, Greenwood J, Moss SE.
De Rossi G, et al.
Eye (Lond). 2023 May;37(7):1517. doi: 10.1038/s41433-022-01988-6.
Eye (Lond). 2023.
PMID: 35228692
Free PMC article.
No abstract available.
Item in Clipboard
LRG1 as a novel therapeutic target in eye disease.
De Rossi G, Da Vitoria Lobo ME, Greenwood J, Moss SE.
De Rossi G, et al.
Eye (Lond). 2022 Feb;36(2):328-340. doi: 10.1038/s41433-021-01807-4. Epub 2022 Jan 5.
Eye (Lond). 2022.
PMID: 34987199
Free PMC article.
Review.
Item in Clipboard
Cite
Cite